CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) Cash from investing

annual CFI:

-$556.00K+$292.95M(+99.81%)
December 31, 2024

Summary

  • As of today (September 10, 2025), CPRX annual cash flow from investing activities is -$556.00 thousand, with the most recent change of +$292.95 million (+99.81%) on December 31, 2024.
  • During the last 3 years, CPRX annual CFI has risen by +$10.46 million (+94.96%).
  • CPRX annual CFI is now -101.49% below its all-time high of $37.22 million, reached on December 31, 2019.

Performance

CPRX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXcash flow metrics

quarterly CFI:

-$26.00K-$26.00K(-100.00%)
June 30, 2025

Summary

  • As of today (September 10, 2025), CPRX quarterly cash flow from investing activities is -$26.00 thousand, with the most recent change of -$26.00 thousand (-100.00%) on June 30, 2025.
  • Over the past year, CPRX quarterly CFI has dropped by -$16.00 thousand (-160.00%).
  • CPRX quarterly CFI is now -100.08% below its all-time high of $31.66 million, reached on December 31, 2019.

Performance

CPRX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXcash flow metrics

TTM CFI:

-$373.00K-$16.00K(-4.48%)
June 30, 2025

Summary

  • As of today (September 10, 2025), CPRX TTM cash flow from investing activities is -$373.00 thousand, with the most recent change of -$16.00 thousand (-4.48%) on June 30, 2025.
  • Over the past year, CPRX TTM CFI has increased by +$130.97 million (+99.72%).
  • CPRX TTM CFI is now -100.89% below its all-time high of $41.71 million, reached on June 30, 2020.

Performance

CPRX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CPRX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+99.8%-160.0%+99.7%
3 y3 years+95.0%-100.3%-104.0%
5 y5 years-101.5%-100.0%-100.9%

CPRX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-106.0%+99.8%-100.3%+100.0%-104.0%+99.9%
5 y5-year-101.5%+99.8%-100.3%+100.0%-100.9%+99.9%
alltimeall time-101.5%+99.8%-100.1%+100.0%-100.9%+99.9%

CPRX Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$26.00K(<-9900.0%)
-$373.00K(+4.5%)
Mar 2025
-
$0.00(-100.0%)
-$357.00K(-35.8%)
Dec 2024
-$556.00K(-99.8%)
-$88.00K(-66.0%)
-$556.00K(-98.6%)
Sep 2024
-
-$259.00K(+2490.0%)
-$38.79M(-70.5%)
Jun 2024
-
-$10.00K(-95.0%)
-$131.34M(+0.0%)
Mar 2024
-
-$199.00K(-99.5%)
-$131.33M(-55.3%)
Dec 2023
-$293.50M(-3287.1%)
-$38.32M(-58.7%)
-$293.50M(+15.0%)
Sep 2023
-
-$92.82M(<-9900.0%)
-$255.18M(+57.0%)
Jun 2023
-
$0.00(-100.0%)
-$162.50M(+6.1%)
Mar 2023
-
-$162.37M(<-9900.0%)
-$153.16M(-1763.1%)
Dec 2022
$9.21M(-183.6%)
$0.00(-100.0%)
$9.21M(+0.4%)
Sep 2022
-
-$132.00K(-101.4%)
$9.17M(-0.7%)
Jun 2022
-
$9.34M(>+9900.0%)
$9.23M(-324.6%)
Mar 2022
-
$0.00(-100.0%)
-$4.11M(-62.7%)
Dec 2021
-$11.02M(+119.9%)
-$41.00K(-39.7%)
-$11.02M(+0.4%)
Sep 2021
-
-$68.00K(-98.3%)
-$10.98M(-47.5%)
Jun 2021
-
-$4.00M(-42.1%)
-$20.92M(+23.6%)
Mar 2021
-
-$6.91M(<-9900.0%)
-$16.92M(+237.7%)
Dec 2020
-$5.01M(-113.5%)
$0.00(-100.0%)
-$5.01M(-118.8%)
Sep 2020
-
-$10.01M(<-9900.0%)
$26.65M(-36.1%)
Jun 2020
-
$0.00(-100.0%)
$41.71M(+31.0%)
Mar 2020
-
$5.00M(-84.2%)
$31.83M(-14.5%)
Dec 2019
$37.22M(-339.8%)
$31.66M(+527.3%)
$37.22M(+89.2%)
Sep 2019
-
$5.05M(-151.1%)
$19.67M(-10.8%)
Jun 2019
-
-$9.88M(-195.0%)
$22.05M(-17.5%)
Mar 2019
-
$10.40M(-26.3%)
$26.72M(-272.1%)
Dec 2018
-$15.53M(>+9900.0%)
$14.11M(+89.9%)
-$15.53M(-47.5%)
Sep 2018
-
$7.43M(-242.5%)
-$29.57M(-20.1%)
Jun 2018
-
-$5.21M(-83.6%)
-$37.03M(+16.4%)
Mar 2018
-
-$31.85M(<-9900.0%)
-$31.82M(>+9900.0%)
Dec 2017
-$4000.00(-100.1%)
$60.80K(-304.0%)
-$3900.00(-100.1%)
Sep 2017
-
-$29.80K(+1555.6%)
$3.67M(-0.8%)
Jun 2017
-
-$1800.00(-94.6%)
$3.70M(+3.2%)
Mar 2017
-
-$33.10K(-100.9%)
$3.58M(+0.9%)
Dec 2016
$3.55M(<-9900.0%)
$3.74M(<-9900.0%)
$3.55M(-2779.1%)
Sep 2016
-
-$900.00(-99.2%)
-$132.60K(-24.7%)
Jun 2016
-
-$116.60K(+77.7%)
-$176.10K(+511.5%)
Mar 2016
-
-$65.60K(-229.9%)
-$28.80K(+343.1%)
Dec 2015
-$6500.00
$50.50K(-213.7%)
-$6500.00(-90.1%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$44.40K(-244.6%)
-$65.90K(+929.7%)
Jun 2015
-
$30.70K(-170.9%)
-$6400.00(-99.9%)
Mar 2015
-
-$43.30K(+386.5%)
-$10.05M(+15.0%)
Dec 2014
-$8.74M(+16.6%)
-$8900.00(-158.9%)
-$8.74M(-43.7%)
Sep 2014
-
$15.10K(-100.2%)
-$15.54M(-21.3%)
Jun 2014
-
-$10.01M(-891.5%)
-$19.75M(+155.9%)
Mar 2014
-
$1.26M(-118.6%)
-$7.72M(+2.9%)
Dec 2013
-$7.50M(-46.7%)
-$6.81M(+62.2%)
-$7.50M(-49.2%)
Sep 2013
-
-$4.20M(-307.6%)
-$14.74M(+39.8%)
Jun 2013
-
$2.02M(+36.1%)
-$10.55M(-16.1%)
Mar 2013
-
$1.49M(-110.6%)
-$12.57M(-10.6%)
Dec 2012
-$14.06M(>+9900.0%)
-$14.05M(<-9900.0%)
-$14.06M(-804.7%)
Sep 2012
-
$0.00(-100.0%)
$2.00M(+0.1%)
Jun 2012
-
-$1900.00(-62.0%)
$1.99M(<-9900.0%)
Mar 2012
-
-$5000.00(-100.2%)
-$8600.00(+138.9%)
Dec 2011
-$3600.00(+24.1%)
$2.00M(<-9900.0%)
-$3600.00(-99.8%)
Sep 2011
-
-$2000.00(-99.9%)
-$2.01M(+0.1%)
Jun 2011
-
-$2.00M(<-9900.0%)
-$2.01M(>+9900.0%)
Mar 2011
-
$0.00(-100.0%)
-$2900.00(0.0%)
Dec 2010
-$2900.00(+26.1%)
-$2900.00(<-9900.0%)
-$2900.00(+26.1%)
Sep 2010
-
$0.00(0.0%)
-$2300.00(0.0%)
Jun 2010
-
$0.00(0.0%)
-$2300.00(0.0%)
Mar 2010
-
$0.00(-100.0%)
-$2300.00(0.0%)
Dec 2009
-$2300.00(+76.9%)
-$2300.00(<-9900.0%)
-$2300.00(<-9900.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2008
-$1300.00(-98.0%)
$0.00(0.0%)
-$1300.00(-88.4%)
Sep 2008
-
$0.00(0.0%)
-$11.20K(-66.2%)
Jun 2008
-
$0.00(-100.0%)
-$33.10K(-47.5%)
Mar 2008
-
-$1300.00(-86.9%)
-$63.10K(-4.2%)
Dec 2007
-$65.90K(+212.3%)
-$9900.00(-54.8%)
-$65.90K(+15.2%)
Sep 2007
-
-$21.90K(-27.0%)
-$57.20K(+34.0%)
Jun 2007
-
-$30.00K(+631.7%)
-$42.70K(+236.2%)
Mar 2007
-
-$4100.00(+241.7%)
-$12.70K(+47.7%)
Dec 2006
-$21.10K(+441.0%)
-$1200.00(-83.8%)
-$8600.00(+16.2%)
Sep 2006
-
-$7400.00
-$7400.00
Dec 2005
-$3900.00(+116.7%)
-
-
Dec 2004
-$1800.00(<-9900.0%)
-
-
Dec 2003
$0.00
-
-

FAQ

  • What is Catalyst Pharmaceuticals, Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. annual CFI year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. quarterly CFI year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. TTM CFI year-on-year change?

What is Catalyst Pharmaceuticals, Inc. annual cash flow from investing activities?

The current annual CFI of CPRX is -$556.00K

What is the all time high annual CFI for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high annual cash flow from investing activities is $37.22M

What is Catalyst Pharmaceuticals, Inc. annual CFI year-on-year change?

Over the past year, CPRX annual cash flow from investing activities has changed by +$292.95M (+99.81%)

What is Catalyst Pharmaceuticals, Inc. quarterly cash flow from investing activities?

The current quarterly CFI of CPRX is -$26.00K

What is the all time high quarterly CFI for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high quarterly cash flow from investing activities is $31.66M

What is Catalyst Pharmaceuticals, Inc. quarterly CFI year-on-year change?

Over the past year, CPRX quarterly cash flow from investing activities has changed by -$16.00K (-160.00%)

What is Catalyst Pharmaceuticals, Inc. TTM cash flow from investing activities?

The current TTM CFI of CPRX is -$373.00K

What is the all time high TTM CFI for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high TTM cash flow from investing activities is $41.71M

What is Catalyst Pharmaceuticals, Inc. TTM CFI year-on-year change?

Over the past year, CPRX TTM cash flow from investing activities has changed by +$130.97M (+99.72%)
On this page